Test Code VITC Ascorbic Acid (Vitamin C), Plasma
Secondary ID
42362Useful For
Identifying vitamin C deficiency
Method Name
Liquid Chromatography Tandem Mass Spectrometry (LC-MS/MS)
Portions of this test are covered by patents held by Quest Diagnostics
Reporting Name
Ascorbic Acid, PSpecimen Type
Plasma HeparinShipping Instructions
Ship specimen frozen on dry ice in amber vial to protect from light.
Specimen Required
Patient Preparation: Fasting overnight (12-14 hours) (infants-collect prior to next feeding). Water can be taken as needed.
Supplies: Amber Frosted Tube, 5 mL (T915)
Collection Container/Tube:
Preferred: Green top (sodium or lithium heparin)
Submission Container/Tube: Amber vial
Specimen Volume: 1 mL
Collection Instructions:
1. Immediately place specimen on wet ice and process within 4 hours of collection.
2. Centrifuge at 4° C, aliquot plasma into amber vial to protect from light.
3. Freeze plasma immediately, ideally at or below -60° C, protected from light.
Specimen Minimum Volume
0.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Heparin | Frozen | 14 days | LIGHT PROTECTED |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | OK |
Gross icterus | OK |
Clinical Information
Vitamin C, also known as L-ascorbic acid or simply ascorbic acid, is a water-soluble vitamin that is naturally present in some foods, added to others, and available as a dietary supplement. Humans, unlike most animals, are unable to synthesize vitamin C endogenously, so it is an essential dietary component. Vitamin C is required for the enzymatic amidation of neuropeptides, production of adrenal cortical steroid hormones, promotion of the conversion of tropocollagen to collagen, and metabolism of tyrosine and folate. It also plays a role in lipid and vitamin metabolism and is a powerful reducing agent or antioxidant. Specific actions include activation of detoxifying enzymes in the liver; antioxidation, interception and destruction of free radicals; preservation and restoration of the antioxidant potential of vitamin E; and blockage of the formation of carcinogenic nitrosamines. In addition, vitamin C appears to function in a variety of other metabolic processes in which its role has not been well characterized.
Prolonged deficiency of vitamin C leads to the development of scurvy, a disease characterized by an inability to form adequate intercellular substance in connective tissues. This results in the formation of swollen, ulcerative lesions in the gums, mouth, and other tissues that are structurally weakened. Early symptoms may include weakness, easy fatigue and listlessness, as well as shortness of breath, and aching joints, bones, and muscles.
The need for vitamin C can be increased by the use of aspirin, oral contraceptives, tetracycline, and a variety of other medications. Psychological stress and advancing age also tend to increase the need for vitamin C. Among older adults, lack of fresh fruit and vegetables often adds vitamin C depletion to the inherently increased need, with development of near-scurvy status.
Reference Values
0.4-2.0 mg/dL
Interpretation
Values below 0.2 mg/dL indicate significant deficiency.
Values greater than or equal to 0.2 mg/dL and less than 0.4 mg/dL are consistent with a moderate risk of deficiency due to inadequate tissue stores.
Values of 0.4 to 2.0 mg/dL indicate adequate supply.
The actual level at which vitamin C is excessive has not been defined. Values above 3.0 mg/dL are suggestive of excess intake. Whether vitamin C in excess is indeed toxic continues to be uncertain. However, limited observations suggest that this condition may induce uricosuria and, in individuals with glucose-6-phosphate dehydrogenase deficiency, may induce increased red blood cell fragility.
Day(s) Performed
Monday through Friday
Report Available
3 to 5 daysSpecimen Retention Time
2 weeksPerforming Laboratory
Mayo Clinic Laboratories in RochesterTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
82180
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
VITC | Ascorbic Acid, P | 1903-4 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
8312 | Ascorbic Acid, P | 1903-4 |